604 related articles for article (PubMed ID: 30678860)
1. Primary Aldosteronism: Present and Future.
Funder JW
Vitam Horm; 2019; 109():285-302. PubMed ID: 30678860
[TBL] [Abstract][Full Text] [Related]
2. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of primary aldosteronism.
Vilela LAP; Almeida MQ
Arch Endocrinol Metab; 2017; 61(3):305-312. PubMed ID: 28699986
[TBL] [Abstract][Full Text] [Related]
5. Primary aldosteronism: Treatment of the disease, and new therapeutic approaches.
Funder J
Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101368. PubMed ID: 31813785
[TBL] [Abstract][Full Text] [Related]
6. Primary aldosteronism: renaissance of a syndrome.
Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
[TBL] [Abstract][Full Text] [Related]
7. [Hyperaldosteronism].
Scholl UI
Internist (Berl); 2021 Mar; 62(3):245-251. PubMed ID: 33599784
[TBL] [Abstract][Full Text] [Related]
8. Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy.
Haase M; Riester A; Kröpil P; Hahner S; Degenhart C; Willenberg HS; Reincke M
J Clin Endocrinol Metab; 2014 Dec; 99(12):4397-402. PubMed ID: 25222758
[TBL] [Abstract][Full Text] [Related]
9. [Primay hyperaldosteronism--diagnostic and treatment].
Potthoff SA; Beuschlein F; Vonend O
Dtsch Med Wochenschr; 2012 Nov; 137(48):2480-4. PubMed ID: 23168980
[TBL] [Abstract][Full Text] [Related]
10. A case of primary aldosteronism with a negative aldosterone-to-renin ratio.
Liu F; Wang L; Ding Y
BMC Cardiovasc Disord; 2021 Jul; 21(1):350. PubMed ID: 34294029
[TBL] [Abstract][Full Text] [Related]
11. Hyperaldosteronism: the internist's hypertensive disease.
Brown CA; Bouldin MJ; Blackston JW; Duddleston DN; Shepherd JM; Hicks GS
Am J Med Sci; 2002 Oct; 324(4):227-31. PubMed ID: 12385496
[TBL] [Abstract][Full Text] [Related]
12. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
Weiner ID
Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism.
Omura M; Sasano H; Saito J; Yamaguchi K; Kakuta Y; Nishikawa T
Hypertens Res; 2006 Nov; 29(11):883-9. PubMed ID: 17345788
[TBL] [Abstract][Full Text] [Related]
14. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Amar L; Baguet JP; Bardet S; Chaffanjon P; Chamontin B; Douillard C; Durieux P; Girerd X; Gosse P; Hernigou A; Herpin D; Houillier P; Jeunemaitre X; Joffre F; Kraimps JL; Lefebvre H; Ménégaux F; Mounier-Véhier C; Nussberger J; Pagny JY; Pechère A; Plouin PF; Reznik Y; Steichen O; Tabarin A; Zennaro MC; Zinzindohoue F; Chabre O
Ann Endocrinol (Paris); 2016 Jul; 77(3):179-86. PubMed ID: 27315757
[TBL] [Abstract][Full Text] [Related]
15. Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
Maiolino G; Ceolotto G; Battistel M; Barbiero G; Cesari M; Amar L; Caroccia B; Padrini R; Azizi M; Rossi GP
Blood Press; 2018 Aug; 27(4):200-205. PubMed ID: 29409357
[TBL] [Abstract][Full Text] [Related]
16. [Conn syndrome as cause of stubborn hypertension. Which hypertensives should you screen?].
Reincke M
MMW Fortschr Med; 2003 Feb; 145(9):37-40. PubMed ID: 12666528
[No Abstract] [Full Text] [Related]
17. Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy.
Yoneda T; Demura M; Takata H; Kometani M; Karashima S; Yamagishi M; Takeda Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1109-13. PubMed ID: 22337911
[TBL] [Abstract][Full Text] [Related]
18. Primary aldosteronism.
Gordon RD
J Endocrinol Invest; 1995; 18(7):495-511. PubMed ID: 9221268
[TBL] [Abstract][Full Text] [Related]
19. Primary aldosteronism, diagnosis and treatment in Japan.
Takeda Y; Karashima S; Yoneda T
Rev Endocr Metab Disord; 2011 Mar; 12(1):21-5. PubMed ID: 21424323
[TBL] [Abstract][Full Text] [Related]
20. Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism.
Nanba AT; Wannachalee T; Shields JJ; Byrd JB; Rainey WE; Auchus RJ; Turcu AF
J Clin Endocrinol Metab; 2019 Feb; 104(2):487-492. PubMed ID: 30239792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
